Given the absence of effective medications for addressing cognitive deficits in PD, our findings that 10 weeks of irisin administration effectively reduced hippocampal inflammation and improved AHN and memory function may provide viable strategies to address these cognitive challenges. The gene discussed is FNDC5; the disease is Parkinson disease.